| 2025-08-23 |
DMALCTUA20468 |
EMERGE BIOSCIENCE PTE LTD |
8208.0 kg |
291229.0
|
BENDAMUSTINE HCL FOR INJECTION,USP, MG/VIAL BENDAMUSTINE HCL FOR INJECTION,USP, MG/VIALL EUCOVORIN CALCIUM FOR INJECTION,USP, MG/VIA LLEUCOVORIN CALCIUM FOR INJECTION,USP, MG/V IALMITOXANTRONE INJECTION, USP, MG/ MLMITO XANTRONE INJECTION, USP, MG/ . MLOX |
| 2025-08-23 |
CITVCD250700011 |
SAGENT PHARMACEUTICALS INC |
2797.0 kg |
848041.0
|
FLUOROURACIL INJECTION, USP, G/ ML |
| 2025-07-22 |
EXDO622911487 |
AMERISOURCE HEALTH SERVICES DBA AMERICAN HEALTH PACKAGING |
2614.0 kg |
280512
|
LEUCOVORIN CALCIUM FOR INJECTION HTS: |
| 2025-06-18 |
CITVCD250500001 |
SAGENT PHARMACEUTICALS INC |
5944.0 kg |
848041
|
FLUOROURACIL INJECTION, USP, 5G/100ML |
| 2025-04-16 |
CHSL506755407CKG |
SAGENT PHARMACEUTICALS |
2809.0 kg |
848041
|
FLUOROURACIL INJECTION,USP,2.5G 50ML TEMPERATURE SETTING 22 CELSIUS VENT CLOSE |
| 2025-04-05 |
EXDO622911326 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
8700.0 kg |
848041
|
OXALIPLATIN INJECTION USP 100MG/20ML;OXA HTS: LIPLATIN INJECTION USP 50MG/10ML HTS: |
| 2025-04-05 |
EXDO622911329 |
NORTHSTAR DISTRIBUTION CENTER 8912 |
7324.0 kg |
848041
|
OXALIPLATIN INJECTION USP 100MG/20ML;OXA HTS: LIPLATIN INJECTION USP 50MG/10ML HTS: |
| 2025-02-07 |
DMALCTUA18698 |
MEITHEAL PHARMACEUTICALS |
8858.0 kg |
848041
|
DOXYCYCLINE FOR INJECTION,USP,100MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,USP,350MG/VIALOXALIPLATIN INJECTION,USP,100MG/20ML-PREMIERPRORXOXALIPLATIN INJECTION,USP,50MG/10MLROPIVACAINE HYDROCHLORIDE INJECTION, USP, 150MG/30ML |
| 2025-01-27 |
DMALCTUA18697 |
MEITHEAL PHARMACEUTICALS |
12077.0 kg |
848041
|
ROPIVACAINE HYDROCHLORIDE INJECTION, USP, 150MG/30ML |
| 2025-01-21 |
DMALCTUA18696 |
MEITHEAL PHARMACEUTICALS |
9931.0 kg |
848041
|
AZACITIDINE FOR INJECTION,100MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,USP,350MG/VIALROPIVACAINE HYDROCHLORIDE INJECTION, USP, 150MG/30MLROPIVACAINE HYDROCHLORIDE INJECTION, USP, 200MG/20ML |
| 2025-01-10 |
CHSL495961080CKG |
SAGENT PHARMACEUTICALS |
5967.0 kg |
848041
|
FLUOROURACIL INJECTION,USP,5G 100ML TEMPERATURE SETTING 22 CELSIUS VENT CLOSE |
| 2024-12-04 |
CHSL492780112CKG |
SAGENT PHARMACEUTICALS |
11968.0 kg |
848041
|
FLUOROURACIL INJECTION,USP,5G 100ML TEMPERATURE SETTING 22 CELSIUS VENT CLOSE FLUOROURACIL INJECTION,USP,5G 100ML TEMPERATURE SETTING 22 CELSIUS VENT CLOSE |
| 2024-07-27 |
DMALCTUA16887 |
INTEGRATED COMMERCIALIZATION SOLUTI |
8656.0 kg |
848041
|
AZACITIDINE FOR INJECTION,100MG/VIAL0.25% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,75MG/30ML0.75% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,225MG/30MLBENDAMUSTINE HCL FOR INJECTION,USP,100MG/VIALBENDAMUSTINE HCL FOR INJECTION,USP,25MG/VIALCYTARABINE INJECTION, 2G/20MLLEUCOVORIN CALCIUM FOR INJECTION,USP,500MG/VIAL |
| 2024-07-27 |
DMALCTUA16868 |
INTEGRATED COMMERCIALIZATION SOLUTI |
11140.0 kg |
848041
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,150MG/30MLMYCOPHENOLATE MOFETIL FOR INJECTION,USP, 500MG/VIAL |
| 2024-07-22 |
DMALCTUA16806 |
INTEGRATED COMMERCIALIZATION SOLUTI |
10175.0 kg |
848041
|
BUPIVACAINE HYDROCHLORIDE INJECTION |
| 2024-07-15 |
DMALCTUA16764 |
INTEGRATED COMMERCIALIZATION SOLUTI |
10054.0 kg |
292151
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,125MG/50ML |
| 2024-07-15 |
DMALCTUA16765 |
INTEGRATED COMMERCIALIZATION SOLUTI |
10028.0 kg |
292151
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,125MG/50ML |
| 2024-07-15 |
DMALCTUA16763 |
INTEGRATED COMMERCIALIZATION SOLUTI |
9282.0 kg |
292151
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,125MG/50ML |
| 2024-07-15 |
DMALCTUA16793 |
INTEGRATED COMMERCIALIZATION SOLUTI |
9300.0 kg |
848041
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,250MG/50MLLEUCOVORIN CALCIUM FOR INJECTION,USP,500MG/VIAL |
| 2024-07-07 |
DMALCTUA16663 |
INTEGRATED COMMERCIALIZATION SOLUTI |
9814.0 kg |
848041
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,125MG/50MLAZACITIDINE FOR INJECTION,100MG/VIAL |
| 2024-07-07 |
DMALCTUA16662 |
INTEGRATED COMMERCIALIZATION SOLUTI |
7207.0 kg |
848041
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,50MG/10ML0.25% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,125MG/50MLMYCOPHENOLATE MOFETIL FOR INJECTION,USP, 500MG/VIAL |
| 2024-07-01 |
DMALCTUA16615 |
INTEGRATED COMMERCIALIZATION SOLUTI |
5930.0 kg |
848041
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,25MG/10ML0.5% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,50MG/10ML |
| 2024-06-22 |
DMALCTUA16226 |
INTEGRATED COMMERCIALIZATION SOLUTI |
3510.0 kg |
848041
|
BLEOMYCIN FOR INJECTION,USP,15U/VIALDACARBAZINE FOR INJECTION,USP,200MG/VIALGEMCITABINE INJECTION, 1G/26.3MLGEMCITABINE INJECTION, 200MG/5.26ML |
| 2024-06-22 |
DMALCTUA16416 |
INTEGRATED COMMERCIALIZATION SOLUTI |
5895.0 kg |
292151
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION, USP,25MG/10ML |
| 2024-06-21 |
DMALCTUA16415 |
INTEGRATED COMMERCIALIZATION SOLUTI |
5607.0 kg |
848041
|
LEUCOVORIN CALCIUM FOR INJECTION,USP, 350MG/VIAL0.25% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,25MG/10ML |
| 2024-06-11 |
EXDO622910818 |
EVERSANA LIFESCIENCE SERVICES |
2806.0 kg |
848041
|
FLUOROURACIL INJECTION HTS: |
| 2024-06-03 |
DMALCTUA16156 |
INTEGRATED COMMERCIALIZATION SOLUTI |
8969.0 kg |
848041
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,250MG/50MLLEUCOVORIN CALCIUM FOR INJECTION,USP, 350MG/VIAL |
| 2024-06-03 |
DMALCTUA16157 |
INTEGRATED COMMERCIALIZATION SOLUTI |
8903.0 kg |
848041
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,250MG/50MLGEMCITABINE FOR INJECTION, USP,200MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,USP, 350MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,USP, 50MG/VIAL |
| 2024-05-29 |
DMALCTUA16153 |
INTEGRATED COMMERCIALIZATION SOLUTI |
9448.0 kg |
848041
|
BUPIVACAINE HYDROCHLORIDE INJECTION |
| 2024-05-08 |
DMALCTUA15874 |
INTEGRATED COMMERCIALIZATION SOLUTI |
8338.0 kg |
292143
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,150MG/30ML |
| 2024-05-08 |
DMALCTUA15883 |
INTEGRATED COMMERCIALIZATION SOLUTI |
9182.0 kg |
848041
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,75MG/30MLCYTARABINE INJECTION, 2G/20MLLEUCOVORIN CALCIUM FOR INJECTION,USP,50MG/VIAL |
| 2024-04-26 |
DMALCTUA15800 |
INTEGRATED COMMERCIALIZATION SOLUTI |
9043.0 kg |
848041
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,75MG/30MLMYCOPHENOLATE MOFETIL FOR INJECTION,USP, 500MG/VIAL |
| 2024-04-26 |
DMALCTUA15760 |
INTEGRATED COMMERCIALIZATION SOLUTI |
11952.0 kg |
848041
|
BUPIVACAINE HYDROCHLORIDE INJECTION |
| 2024-04-26 |
DMALCTUA15799 |
INTEGRATED COMMERCIALIZATION SOLUTI |
9932.0 kg |
292151
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,75MG/30ML |
| 2024-04-25 |
DMALCTUA15699 |
INTEGRATED COMMERCIALIZATION SOLUTI |
5342.0 kg |
848041
|
0.75% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,225MG/30ML0.75% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,75MG/10MLDECITABINE FOR INJECTION,50MG/VIAL GEMCITABINE FOR INJECTION,USP,1G/VIAL |
| 2024-04-25 |
DMALCTUA15735 |
INTEGRATED COMMERCIALIZATION SOLUTI |
1664.0 kg |
848041
|
GEMCITABINE INJECTION, 2G/52.6ML |
| 2024-04-11 |
DMALCTUA15550 |
INTEGRATED COMMERCIALIZATION SOLUTI |
5704.0 kg |
848041
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,50MG/10ML0.75% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,75MG/10MLAZACITIDINE FOR INJECTION,100MG/VIAL |
| 2024-04-11 |
DMALCTUA15549 |
INTEGRATED COMMERCIALIZATION SOLUTI |
7119.0 kg |
848041
|
0.25% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,25MG/10ML0.75% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,225MG/30MLAZACITIDINE FOR INJECTION,100MG/VIAL |
| 2024-04-10 |
SYLCWT240200016 |
SAGENT PHARMACEUTICALS INC |
5941.0 kg |
300490
|
FLUOROURACIL INJECTION, 5G/100ML TEMPERATURE SETTING AT 22 DEGREE CELSIUS HS CODE:3004909093 |
| 2024-04-10 |
SYLCWT240200017 |
SAGENT PHARMACEUTICALS INC |
5953.0 kg |
300490
|
FLUOROURACIL INJECTION, 5G/100ML TEMPERATURE SETTING AT 22 DEGREE CELSIUS HS CODE:3004909093 |
| 2024-04-10 |
SYLCWT240200015 |
SAGENT PHARMACEUTICALS INC |
8798.0 kg |
300490
|
FLUOROURACIL INJECTION, 5G/100ML FLUOROURACILINJECTION, 2.5G/50ML TEMPERATURE SETTING AT 22 DEGREE CELSIUS HS CODE:3004909093 |
| 2024-03-23 |
DMALCTUA15233 |
INTEGRATED COMMERCIALIZATION SOLUTI |
12122.0 kg |
292151
|
0.25% BUPIVACAINE HYDROCHLORIDE |
| 2024-03-23 |
DMALCTUA15370 |
INTEGRATED COMMERCIALIZATION SOLUTI |
6927.0 kg |
848041
|
0.5% BUPIVACAINE HYDROCHLORIDE INJECTION,USP,150MG/30MLAZACITIDINE FOR INJECTION,100MG/VIALMYCOPHENOLATE MOFETIL FOR INJECTION,USP, 500MG/VIAL |
| 2024-03-09 |
DMALCTUA15112 |
INTEGRATED COMMERCIALIZATION SOLUTI |
4603.0 kg |
848041
|
GEMCITABINE FOR INJECTION, USP,200MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,USP,100MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,USP,50MG/VIALVANCOMYCIN HYDROCHLORIDE FOR INJECTION,USP,5G /PHARMACY BULK PACKAGE |
| 2024-02-10 |
DMALCTUA14802 |
INTEGRATED COMMERCIALIZATION SOLUTI |
3829.0 kg |
848041
|
AZACITIDINE FOR INJECTION,100MG/VIALAZACITIDINE FOR INJECTION,100MG/VIAL-NOVAPLUSVANCOMYCIN HYDROCHLORIDE FOR INJECTION,USP,10G /PHARMACY BULK PACKAGE |
| 2024-01-30 |
DMALCTUA14801 |
INTEGRATED COMMERCIALIZATION SOLUTI |
7798.0 kg |
848041
|
VANCOMYCIN HYDROCHLORIDE FOR INJECTION,USP,750MG/VIALVANCOMYCIN HYDROCHLORIDE FOR INJECTION,USP,10G/PHARMACY BULK PACKAGE |
| 2024-01-18 |
DMALCTUA14727 |
INTEGRATED COMMERCIALIZATION SOLUTI |
4871.0 kg |
848041
|
LEUCOVORIN CALCIUM FOR INJECTION,100MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,350MG/VIALMYCOPHENOLATE MOFETIL FOR INJECTION,500MG/VIALAZ ACITIDINE FOR INJECTION,100MG/VIAL |
| 2024-01-18 |
DMALCTUA14721 |
INTEGRATED COMMERCIALIZATION SOLUTI |
4793.0 kg |
848041
|
GEMCITABINE INJECTION |
| 2024-01-05 |
DMALCTUA14614 |
INTEGRATED COMMERCIALIZATION SOLUTI |
4370.0 kg |
848041
|
LEUCOVORIN CALCIUM FOR INJECTION,USP,200MG/VIALLEUCOVORIN CALCIUM FOR INJECTION,USP,350MG/VIALMYCOPHENOLATE MOFETIL FOR INJECTION,USP,500MG/VIAL |
| 2023-12-24 |
DMALCTUA14530 |
INTEGRATED COMMERCIALIZATION SOLUTI |
4078.0 kg |
280512
|
LEUCOVORIN CALCIUM FOR INJECTION,USP,200MG/VIAL |